Arkansas Family Care Network - Medicare in North Little Rock, AR

Arkansas Family Care Network is a medicare enrolled "Family Medicine" provider in North Little Rock, Arkansas. Their current practice location is 5125 Northshore Dr, North Little Rock, Arkansas. You can reach out to their office (for appointments etc.) via phone at (501) 224-1690.

Arkansas Family Care Network is licensed to practice in * (Not Available) (license number ) and it also participates in the medicare program. Arkansas Family Care Network is enrolled with medicare and should accept medicare assignments and since they are enrolled in medicare, they may order Medicare Part D Prescription drugs, if eligible. The facility's NPI Number is 1497718134.

Contact Information

Arkansas Family Care Network
5125 Northshore Dr,
North Little Rock, AR 72118-5315
(501) 224-1690
(501) 224-1927



Healthcare Provider's Profile

Full NameArkansas Family Care Network
TypeFacility
SpecialityFamily Medicine
Location5125 Northshore Dr, North Little Rock, Arkansas
Accepts Medicare AssignmentsMedicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1497718134
  • Provider Enumeration Date: 04/11/2006
  • Last Update Date: 04/19/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 0648256800
  • Enrollment ID: O20040628000962

Medical Identifiers

Medical identifiers for Arkansas Family Care Network such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1497718134NPI-NPPES
104997002MedicaidAR

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
111N00000XChiropractor (* (Not Available))Secondary
207K00000XAllergy & Immunology (* (Not Available))Secondary
207N00000XDermatology (* (Not Available))Secondary
207Q00000XFamily Medicine (* (Not Available))Primary
207R00000XInternal Medicine (* (Not Available))Secondary
207RH0003XInternal Medicine - Hematology & Oncology (* (Not Available))Secondary
207V00000XObstetrics & Gynecology (* (Not Available))Secondary
207VE0102XObstetrics & Gynecology - Reproductive Endocrinology (* (Not Available))Secondary
208000000XPediatrics (* (Not Available))Secondary
225100000XPhysical Therapist (* (Not Available))Secondary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Arkansas Family Care Network acts as a billing entity for following providers:
Provider NameDarby H Brighton
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1932134566
PECOS PAC ID: 0345136024
Enrollment ID: I20040227000848

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameMichael M Miller
Provider TypePractitioner - Obstetrics/gynecology
Provider IdentifiersNPI Number: 1376552315
PECOS PAC ID: 7517949290
Enrollment ID: I20040605000182

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameJay A Flaming
Provider TypePractitioner - Dermatology
Provider IdentifiersNPI Number: 1578506218
PECOS PAC ID: 0941237234
Enrollment ID: I20050719000328

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameKent J Covert
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1568414415
PECOS PAC ID: 0941235287
Enrollment ID: I20051005000662

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameMilton C Roach
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1922005974
PECOS PAC ID: 0749200327
Enrollment ID: I20051128000657

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameGary Harper
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1689651911
PECOS PAC ID: 2961424817
Enrollment ID: I20051220000831

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameGunnar Heidman Gibson
Provider TypePractitioner - Dermatology
Provider IdentifiersNPI Number: 1427043595
PECOS PAC ID: 7113969874
Enrollment ID: I20061207000186

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameJames Timothy Hodges
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1902802465
PECOS PAC ID: 7012017114
Enrollment ID: I20070702000500

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameKevin C Hiegel
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1235122383
PECOS PAC ID: 8123004314
Enrollment ID: I20070824000264

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameKevin D Roberts
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1336132372
PECOS PAC ID: 4688650872
Enrollment ID: I20070824000726

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameThomas C Moore
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1780677666
PECOS PAC ID: 2860478054
Enrollment ID: I20070824000742

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameChristopher L Pittman
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1407860539
PECOS PAC ID: 7911903414
Enrollment ID: I20081023000282

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameStephen B Tilley
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1205833738
PECOS PAC ID: 5698751881
Enrollment ID: I20100222000939

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameRobert S Tucker
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1205829710
PECOS PAC ID: 4880670074
Enrollment ID: I20100223000899

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameKenneth Johnston
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1245224229
PECOS PAC ID: 8022094218
Enrollment ID: I20100224000952

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameDaniel H Felton
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1174517056
PECOS PAC ID: 4789729849
Enrollment ID: I20100301000963

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameBarry G Ford
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1982698965
PECOS PAC ID: 5294711487
Enrollment ID: I20100319000794

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameHarold H Hedges
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1407849896
PECOS PAC ID: 7618953803
Enrollment ID: I20100323000837

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameIrol T Gray
Provider TypePractitioner - Internal Medicine
Provider IdentifiersNPI Number: 1164429981
PECOS PAC ID: 0244216430
Enrollment ID: I20100427000294

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameJoshua A Motes
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1619105277
PECOS PAC ID: 5092900977
Enrollment ID: I20101117001135

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameMarcus Y Chu
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1609188614
PECOS PAC ID: 3274774484
Enrollment ID: I20130731000622

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameSarah B Mckenzie
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1043546930
PECOS PAC ID: 1456589381
Enrollment ID: I20140122000842

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameBenjamin G Mcdonald
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1184935827
PECOS PAC ID: 5294953279
Enrollment ID: I20140904002153

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameAshley A Blackwood
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1295276285
PECOS PAC ID: 0840576047
Enrollment ID: I20170424000219

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameJacey Guthrie
Provider TypePractitioner - Dermatology
Provider IdentifiersNPI Number: 1174942528
PECOS PAC ID: 9638498298
Enrollment ID: I20180620002338

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameLauren Leeann Sheffield
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1154800704
PECOS PAC ID: 3173875531
Enrollment ID: I20181012000284

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameReed Michael Thomas
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1427408038
PECOS PAC ID: 7315201167
Enrollment ID: I20190706000212

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameJohn Freeland Jayroe
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1801246129
PECOS PAC ID: 2567754443
Enrollment ID: I20190710001763

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameMorgan Stobaugh
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1780137349
PECOS PAC ID: 3476973520
Enrollment ID: I20201012002076

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameJonathan Berry
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1346731932
PECOS PAC ID: 1658629928
Enrollment ID: I20201027001509

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameKelly Glenn Thompson-davis
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1467043224
PECOS PAC ID: 8123434651
Enrollment ID: I20210309000884

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameJordan Moore
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1902488380
PECOS PAC ID: 2163829078
Enrollment ID: I20210920002847

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameVan Hoytt Davis
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1548252653
PECOS PAC ID: 2769400316
Enrollment ID: I20210924001381

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameMelinda Michelle Patterson
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1497218721
PECOS PAC ID: 5395126502
Enrollment ID: I20220719004032

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameTierney Russell
Provider TypePractitioner - Nurse Practitioner
Provider IdentifiersNPI Number: 1184324113
PECOS PAC ID: 3375908767
Enrollment ID: I20230509001268

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameQinqing Yang
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1952002032
PECOS PAC ID: 6709243421
Enrollment ID: I20230612000033

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameElizabeth Carey Sullivan
Provider TypePractitioner - Family Practice
Provider IdentifiersNPI Number: 1366070765
PECOS PAC ID: 0749601276
Enrollment ID: I20230908002630

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Provider NameJacob Norris
Provider TypePractitioner - Physical Therapist In Private Practice
Provider IdentifiersNPI Number: 1770242448
PECOS PAC ID: 4183011620
Enrollment ID: I20240117002054

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Arkansas Family Care Network is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Arkansas Family Care Network
Po Box 15056,
Little Rock, AR 72231-5056

Ph: (501) 224-1690
Arkansas Family Care Network
5125 Northshore Dr,
North Little Rock, AR 72118-5315

Ph: (501) 224-1690

News Archive

Fecal transplants transfer bacterial viruses that appear to be harmless to humans

Communities of viruses can be transferred during fecal transplants, according to a study published this week in mBio, an online open-access journal of the American Society for Microbiology. Fortunately for patients who use this procedure, the viruses found to be transmitted in this study appear to be harmless to humans.

DARA BioSciences closes registered public offering

On December 28, 2010, DARA BioSciences, Inc. announced that it planned to raise up to $4 million through a registered public offering of units comprised of shares of Series A convertible preferred stock and warrants to purchase shares of common stock. Due to strong demand for the offered securities, the Company increased the size of the offering to up to $4.8 million.

Gene therapy for retinitis pigmentosa

An international team of scientists and clinicians from the United States and Saudi Arabia are working to develop gene therapy for treating a rare, hereditary retinal disease.

Study provides new insight into how obesity, insulin resistance can affect cognition

Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.

Oxford VR raises £3.2m to boost innovation in VR for mental health problems

Oxford VR, a spinout company from the University of Oxford, has raised £3.2m with investors including Oxford Sciences Innovation, University of Oxford, Force Over Mass, RT Capital and GT Healthcare Capital Partners.

Read more News

› Verified 8 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.